Stereoselective determination of S-naproxen in tablets by capillary electrophoresis

被引:57
作者
Fillet, M [1 ]
Fotsing, L [1 ]
Bonnard, J [1 ]
Crommen, J [1 ]
机构
[1] Univ Liege, Inst Pharm, Dept Pharmaceut Analyt Chem, B-4000 Liege 1, Belgium
关键词
capillary electrophoresis; enantioseparation; method validation; naproxen;
D O I
10.1016/S0731-7085(98)00218-0
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A capillary electrophoresis (CE) method was developed for the stereoselective determination of the non-steroidal anti-inflammatory drug (NSAID), S-naproxen, in tablets. Several beta-cyclodextrin derivatives (CDs) were tested as chiral selectors, including sulfobutyl-beta-CD (SBCD), carboxymethyl-beta-CD(CMCD), dimethyl-beta-CD (DMCD) and trimethyl-beta-CD (TMCD), in a phosphoric acid/triethanolamine pH 3 buffer. Under these conditions, the analyte was mainly present in an uncharged form and therefore, the use a neutral CD(DMCD or TMCD) alone could not lead to enantiomeric separation. On the contrary, by addition of a charged CD (SBCD or CMCD) to the running buffer, giving the analyte enantiomers an adequate mobility, chiral resolution could be achieved, although the resolution values obtained in this case were not quite satisfactory (Rs < 1.5). Dual systems, based on the use of mixtures of charged and neutral CDs, were then investigated. The SBCD/TMCD system was found to be particularly well suited to the enantioseparation of naproxen and after optimisation of the concentrations of both CDs, a resolution value of 5.4 could be obtained. The method was validated for the determination of R-naproxen (enantiomeric impurity) in the 0.1-2% range, using the racemic mixture of the analyte. A second validation was performed in the 50-150% range for the quantitation of S-naproxen. In both cases, good results with respect to linearity, precision and accuracy were obtained. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 19 条
[1]   QUANTITATIVE ASPECTS OF THE APPLICATION OF CAPILLARY ELECTROPHORESIS TO THE ANALYSIS OF PHARMACEUTICALS AND DRUG-RELATED IMPURITIES [J].
ALTRIA, KD .
JOURNAL OF CHROMATOGRAPHY, 1993, 646 (02) :245-257
[2]   VALIDATION OF A CAPILLARY ELECTROPHORESIS METHOD FOR THE ENANTIOMERIC PURITY TESTING OF FLUPAROXAN [J].
ALTRIA, KD ;
WALSH, AR ;
SMITH, NW .
JOURNAL OF CHROMATOGRAPHY, 1993, 645 (01) :193-196
[3]   QUANTITATIVE APPLICATIONS AND VALIDATION OF THE RESOLUTION OF ENANTIOMERS BY CAPILLARY ELECTROPHORESIS [J].
ALTRIA, KD ;
GOODALL, DM ;
ROGAN, MM .
ELECTROPHORESIS, 1994, 15 (06) :824-827
[4]  
CAPORALGAUTIER J, 1992, PHARM PRAT, V2, P202
[5]  
Chankvetadze B., 1997, CAPILLARY ELECTROPHO
[6]  
*COUNC EUR, 1996, EUR PHARM
[7]   ENANTIOMERIC PURITY DETERMINATION OF PROPRANOLOL BY CYCLODEXTRIN-MODIFIED CAPILLARY ELECTROPHORESIS [J].
FILLET, M ;
BECHET, I ;
CHIAP, P ;
HUBERT, P ;
CROMMEN, J .
JOURNAL OF CHROMATOGRAPHY A, 1995, 717 (1-2) :203-209
[8]   Enantioseparation of nonsteroidal anti-inflammatory drugs by capillary electrophoresis using mixtures of anionic and uncharged beta-cyclodextrins as chiral additives [J].
Fillet, M ;
Hubert, P ;
Crommen, J .
ELECTROPHORESIS, 1997, 18 (06) :1013-1018
[9]  
Fillet M, 1996, HRC-J HIGH RES CHROM, V19, P669
[10]  
FILLET M, IN PRESS J CHROMAT A